Figure 2.
Kaplan–Meier plot depicting real-world time on treatment (rwToT) with first-line pembrolizumab monotherapy for patients with advanced NSCLC, according to ECOG performance status.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.